NPA, Informed-Choice Pact: Health And Wellness Industry News Roundup
This article was originally published in The Rose Sheet
Executive Summary
CRN: bioactive nutrient guide needed; discuss 'healthy' in labeling at FDA public meetinCanadian supplement firms merge; and more news in brief.
You may also be interested in...
Industry Groups Suggest 'Healthy Eating' Approach On Label Enforcement
Supplement industry trade associations urge FDA to consider expanding the scope of products eligible to use “healthy” on product labels, though NPA says the issue could be on the backburner for the Trump administration.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.